Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.550
+0.020 (0.57%)
Oct 30, 2026, 12:55 PM EDT - Market open

Molecular Partners AG Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
134
Market Cap
139.39M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 20244.97M-2.07M-29.38%
Dec 31, 20237.04M-182.56M-96.29%
Dec 31, 2022189.60M179.85M1,843.82%
Dec 31, 20219.75M410.00K4.39%
Dec 31, 20209.34M-11.04M-54.16%
Dec 31, 201920.38M10.03M96.84%
Dec 31, 201810.36M-9.66M-48.27%
Dec 31, 201720.02M-3.02M-13.13%
Dec 31, 201623.04M-6.08M-20.88%
Dec 31, 201529.12M2.49M9.37%
Dec 31, 201426.63M-5.79M-17.87%
Dec 31, 201332.42M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MacroGenics175.14M
Codexis77.68M
Atrium Therapeutics35.84M
Upstream Bio3.16M
Veraxa Biotech AG29.54K
Revenue Rankings